Search by Drug Name or NDC
NDC 00132-0202-20 Pedia-Lax 3.5; 9.5 g/66mL; g/66mL Details
Pedia-Lax 3.5; 9.5 g/66mL; g/66mL
Pedia-Lax is a RECTAL ENEMA in the HUMAN OTC DRUG category. It is labeled and distributed by C.B. Fleet Company, Inc.. The primary component is SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC.
Product Information
| NDC | 00132-0202 |
|---|---|
| Product ID | 0132-0202_b5e01333-93ab-4725-b9b5-bb17c5968729 |
| Associated GPIs | 46109902105110 |
| GCN Sequence Number | 062501 |
| GCN Sequence Number Description | sodium phosphate,mono-dibasic ENEMA 9.5-3.5/59 RECTAL |
| HIC3 | Q3S |
| HIC3 Description | LAXATIVES, LOCAL/RECTAL |
| GCN | 98276 |
| HICL Sequence Number | 001330 |
| HICL Sequence Number Description | SODIUM PHOSPHATE,MONOBASIC/SODIUM PHOSPHATE,DIBASIC |
| Brand/Generic | Brand |
| Proprietary Name | Pedia-Lax |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | sodium phosphate, dibasic and sodium phosphate, monobasic |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | ENEMA |
| Route | RECTAL |
| Active Ingredient Strength | 3.5; 9.5 |
| Active Ingredient Units | g/66mL; g/66mL |
| Substance Name | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC |
| Labeler Name | C.B. Fleet Company, Inc. |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00132-0202-20 (00132020220)
| NDC Package Code | 0132-0202-20 |
|---|---|
| Billing NDC | 00132020220 |
| Package | 66 mL in 1 BOTTLE, WITH APPLICATOR (0132-0202-20) |
| Marketing Start Date | 2002-05-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |